RETRACTED: Tanshinone-IIA attenuates the deleterious effects of oxidative stress in osteoporosis through the NF-κB signaling pathway (Retracted Article)

被引:39
作者
Zhu, Shaowen [1 ]
Wei, Wanfu [2 ]
Liu, Zhiwei [3 ]
Yang, Yang [2 ]
Jia, Haobo [2 ]
机构
[1] Tianjin Med Univ Gen Hosp, Dept Orthoped, Tianjin 300052, Peoples R China
[2] Tianjin Hosp, Dept Orthoped, 406 Jiefang South Rd, Tianjin 300211, Peoples R China
[3] Peking Univ, Basic Med Inst, Publ Hlth Ctr, Beijing 100871, Peoples R China
关键词
osteoclasts; tanshinone IIA; oxidative stress; nuclear factor-kappa B; BONE-MINERAL DENSITY; IN-VITRO; CELLS; EXPRESSION;
D O I
10.3892/mmr.2018.8741
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Osteoclasts are responsible for bone resorption caused by bone microstructural damage and bonerelated disorders. Evidence shows that tanshinone IIA (Tan-IIA), a traditional Chinese medicine, is used clinically as a drug for the treatment of cardiovascular and cerebrovascular diseases. However, the efficacy and mechanism underlying the effect of Tan-IIA on the viability of osteoclasts remain to be fully elucidated. The present study investigated the therapeutic effects of Tan-IIA on osteoblast differentiation and oxidative stress in vitro and in vivo. Cell viability was analyzed and oxidative stress was examined in the osteoblasts. Wnt1(sw/sw) mice were used to investigate the therapeutic effects of Tan-IIA on spontaneous tibia fractures and severe osteopenia. The bone strength, collagen and mineral were examined in the tibia. Osteoblast activity was also analyzed in the experimental mice. The Tan-IIA-induced differentiation of osteoclasts and the mechanism of action were investigated in osteocytes. The data showed that Tan-IIA treatment improved cell viability. The data also demonstrated that Tan-IIA decreased the levels of H2O2, accumulation of reactive oxygen species and apoptosis of osteoblasts. Tan-IIA inhibited the deleterious outcomes triggered by oxidative stress. In addition, Tan-IIA inhibited the activation of nuclear factor (NF)-kappa B and its target genes, tumor necrosis factor (TNF)-alpha, inducible nitric oxide synthase and cyclooxygenase 2, and increased the levels of TNF receptor-associated factor 1 and inhibitor of apoptosis protein-1/2 in the osteocytes. Furthermore, it was shown that Tan-IIA reduced the propensity to fractures and severe osteopenia in mice with osteoporosis. Tan-IIA also exhibited improved bone strength, mineral and collagen in the bone matrix of the experimental mice. It was found that the Tan-IIA-mediated benefits on osteoblast activity and function were through the NF-kappa B signaling pathway. Taken together, the data obtained in the present study suggested that Tan-IIA had protective effects against oxidative stress in osteoblastic differentiation in mice with osteoporosis by regulating the NF-kappa B signaling pathway.
引用
收藏
页码:6969 / 6976
页数:8
相关论文
共 50 条
  • [31] Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-κB/receptor activator of NF-κBligand/osteoprotegerin (RANK/RANKL/OPG) pathway
    He, Xiao-Feng
    Zhang, Long
    Zhang, Chun-Hua
    Zhao, Con-Ran
    Li, Heng
    Zhang, Ling-Fei
    Tian, Guo-Feng
    Guo, Ming-Feng
    Dai, Zheng
    Sui, Fu-Ge
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2017, 17 (04) : 295 - 301
  • [32] RETRACTED: Eupafolin induces apoptosis and autophagy of breast cancer cells through PI3K/AKT, MAPKs and NF-κB signaling pathways (Retracted Article)
    Wei, Jiahui
    Ding, Yu
    Liu, Xinmiao
    Liu, Qing
    Lu, Yiran
    He, Song
    Yuan, Bao
    Zhang, Jiabao
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [33] Tanshinone IIA alleviate atherosclerosis and hepatic steatosis via down-regulation of MAPKs/NF-κB signaling pathway
    Zhang, Yifan
    Wang, Jiarou
    Yang, Shuo
    Kou, Haixin
    Liu, Ping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 152
  • [34] RETRACTED: Butylphthalide Inhibits TLR4/NF-κB Pathway by Upregulation of miR-21 to Have the Neuroprotective Effect (Retracted Article)
    Zhan, Lan
    Pang, Yu
    Jiang, Hao
    Zhang, Shicun
    Jin, Hongwei
    Chen, Jing
    Jia, Cuiying
    Guo, Hongyan
    Mu, Zhuang
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [35] Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats
    Wang, Dong-Tao
    Huang, Ren-Hua
    Cheng, Xin
    Zhang, Zhi-Hua
    Yang, Ya-Jun
    Lin, Xin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 26 (01) : 4 - 12
  • [36] RETRACTED: NF-κB inhibits the occurrence of type 1 diabetes through microRNA-150-dependent PUMA degradation (Retracted article. See vol. 324, 2023)
    Tian, Jing
    Pan, Wei
    Xu, Xiaoheng
    Tian, Xin
    Zhang, Meng
    Hu, Qibo
    LIFE SCIENCES, 2020, 255
  • [37] RETRACTED ARTICLE: Rhynchophylline attenuates migraine in trigeminal nucleus caudalis in nitroglycerin-induced rat model by inhibiting MAPK/NF-кB signaling
    Tianbao Lai
    Liangyi Chen
    Xingyu Chen
    Jianquan He
    Peiyu Lv
    Hua Ge
    Molecular and Cellular Biochemistry, 2019, 461 : 205 - 212
  • [38] Sargassum serratifolium attenuates RANKL-induced osteoclast differentiation and oxidative stress through inhibition of NF-κB and activation of the Nrf2/HO-1 signaling pathway
    Kim, Hong Jae
    Park, Cheol
    Kim, Gi-Young
    Park, Eui Kyun
    Jeon, You-Jin
    Kim, Suhkmann
    Hwang, Hye Jin
    Choi, Yung Hyun
    BIOSCIENCE TRENDS, 2018, 12 (03) : 257 - 265
  • [39] Correlation between oxidative stress and NF-κB signaling pathway in the obesity-asthma mice
    Liu, Xiaomei
    Yi, Mingji
    Jin, Rong
    Feng, Xueying
    Ma, Liang
    Wang, Yanxia
    Shan, Yanchun
    Yang, Zhaochuan
    Zhao, Baochun
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (05) : 3735 - 3744
  • [40] RETRACTED: Down-regulated LAMA4 inhibits oxidative stress-induced apoptosis of retinal ganglion cells through the MAPK signaling pathway in rats with glaucoma (Retracted Article)
    Wang, Chong
    Ren, Ya-Lin
    Zhai, Jin
    Zhou, Xiao-Yan
    Wu, Jing
    CELL CYCLE, 2019, 18 (09) : 932 - 948